Evidence map›Paper›PMID 41736134›Full record

ArticleFluids and barriers of the CNS2026

Consequences of irradiation on blood-brain tumor barrier model of Diffuse Midline Glioma: characterization of physical and metabolic properties.

Marine Carroué, Eloise Happernegg, Flavie Perrot, Marie-Christine Boucau, Lucie Dehouck, Emmanuel Sevin, Mélanie Arcicasa, Joanne Balsamelli, Fumitaka Shimizu, Takashi Kanda and 6 more

Abstract read
In one paragraph

Article in Fluids and barriers of the CNS, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Marine CarrouéUniv. Artois, UR 2465, Laboratoire de la Barrière Hémato-Encéphalique (LBHE), Lens, F-62300, France.
Eloise HapperneggUniv. Artois, UR 2465, Laboratoire de la Barrière Hémato-Encéphalique (LBHE), Lens, F-62300, France.
Flavie PerrotUniv. Artois, UR 2465, Laboratoire de la Barrière Hémato-Encéphalique (LBHE), Lens, F-62300, France.
Marie-Christine BoucauUniv. Artois, UR 2465, Laboratoire de la Barrière Hémato-Encéphalique (LBHE), Lens, F-62300, France.
Lucie DehouckUniv. Artois, UR 2465, Laboratoire de la Barrière Hémato-Encéphalique (LBHE), Lens, F-62300, France.
Emmanuel SevinUniv. Artois, UR 2465, Laboratoire de la Barrière Hémato-Encéphalique (LBHE), Lens, F-62300, France.
Mélanie ArcicasaUniv. Lille, CNRS, Inserm, CHU Lille, Institut de Recherche Contre Le Cancer de Lille, UMR9020 - UMR-S 1277 - Canther Cancer Heterogeneity, Plasticity and Resistance to Therapies, Lille, F-59000, France.
Joanne BalsamelliUniv. Lille, CNRS, Inserm, CHU Lille, Institut de Recherche Contre Le Cancer de Lille, UMR9020 - UMR-S 1277 - Canther Cancer Heterogeneity, Plasticity and Resistance to Therapies, Lille, F-59000, France.
Fumitaka ShimizuDepartment of Neurology and Clinical Neuroscience, Yamaguchi University Graduate School of Medicine, Ube, Japan.
Takashi KandaDepartment of Neurology, Neuromuscular Center Yoshimizu Hospital, Shimonoseki, Japan.
Angel M CarcabosoPediatric Cancer Program, Institut de Recerca Sant Joan de Deu (IRSJD), Hospital Sant Joan de Deu, Esplugues de Llobregat, Barcelona, 08950, Spain.
Robert-Alain ToillonUniv. Lille, CNRS, Inserm, CHU Lille, Institut de Recherche Contre Le Cancer de Lille, UMR9020 - UMR-S 1277 - Canther Cancer Heterogeneity, Plasticity and Resistance to Therapies, Lille, F-59000, France.
Maxime CulotUniv. Artois, UR 2465, Laboratoire de la Barrière Hémato-Encéphalique (LBHE), Lens, F-62300, France.
Samuel MeignanUniv. Lille, CNRS, Inserm, CHU Lille, Institut de Recherche Contre Le Cancer de Lille, UMR9020 - UMR-S 1277 - Canther Cancer Heterogeneity, Plasticity and Resistance to Therapies, Lille, F-59000, France.
Fabien GosseletUniv. Artois, UR 2465, Laboratoire de la Barrière Hémato-Encéphalique (LBHE), Lens, F-62300, France.
Caroline MysiorekUniv. Artois, UR 2465, Laboratoire de la Barrière Hémato-Encéphalique (LBHE), Lens, F-62300, France. caroline.mysiorek@univ-artois.fr.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundDiffuse midline glioma (DMG) is a rare and aggressive pediatric brain tumor, with a median survival of less than 12 months. Due to its location in the pons, surgical resection is impossible, leaving radiation therapy as the only palliative treatment option. Unfortunately, radiation therapy yields minimal improvement in survival. Thus, characterization of the vascular component of the DMG microenvironment at the cellular and molecular levels following radiotherapy to improve therapeutic strategies.

methodsA human syngeneic blood-brain tumor barrier (BBTB) in vitro model, comprising endothelial cells, pericytes and DMG cells was submitted to a single dose of radiation (2 Gγ to 6 Gγ) and was characterized for its physical and metabolic properties over a period of 7 days post-exposure. The results were then compared to the effects of the same irradiation protocol on a physiologic blood-brain barrier (BBB) model.

resultsFollowing irradiation, the endothelial permeability of the BBB ECs and the BBTB ECs was preserved for up to 7 days but associated with Claudin-5 heterogeneous distribution at the ECs borders and decrease of expression after irradiation. Nevertheless, irradiation was found to potentiate the effect of TNFα on the physical integrity of the BBB, which was less important for the BBTB. The metabolic properties of the BBB and BBTB were modulated by radiation at the transcriptional level. Interestingly, different regulations were observed in endothelial cells and pericytes. Notably, pericytes have demonstrated compensatory effects. Immunoblots confirmed the decrease of BCRP, MRP4 and MFSD2A in BBTB endothelial cells after irradiation. Despite significant reduced efficiency, P-gp/BCRP efflux pump activity remains functional in endothelial cells and pericytes following irradiation.

conclusionsIrradiation sensitizes the BBB, but to a lesser extent the BBTB, to the effects of pro-inflammatory cytokines. The observed decrease in P-gp/BCRP activity, as well as the involvement of MFSD2A, MRP4 and Claudin-5 regulation, warrant further investigations.

Indexed as

Blood-Brain BarrierBrain NeoplasmsGliomaATP Binding Cassette Transporter, Subfamily G, Member 2Cell Line, TumorClaudin-5Endothelial CellsHumansPericytesATP Binding Cassette Transporter, Subfamily G, Member 2Claudin-5Blood-brain barrierBlood-tumor barrier modelBrain tumorDIPGDMGEfflux pumpsEndothelial cellsInflammationMFSD2APericytesRadiotherapyResistance to treatment

Identifiers

PMID41736134
PMCPMC12961863

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.